Novo Holdings A/S SEC Filings

Filed On	Filing
31 Aug 2026	N-PX
14 Aug 2026	SCHEDULE 13G
14 Aug 2026	SCHEDULE 13G
14 Aug 2026	13F-HR
10 Aug 2026	SCHEDULE 13G
31 Jul 2026	SCHEDULE 13D/A
30 Jul 2026	144
15 May 2026	SCHEDULE 13G/A
15 May 2026	13F-HR
06 May 2026	Form 4: Novo Holdings A/S, 10% owner · Hemab Therapeutics Holdings Inc Received 4,180,550 shares by conversion
05 May 2026	Form 4: Novo Holdings A/S, 10% owner · Avalyn Pharma Inc Received 3,327,734 shares by conversion · Bought 555,555 shares ($10M)
30 Apr 2026	Form 3: Novo Holdings A/S, 10% owner · Hemab Therapeutics Holdings Inc
29 Apr 2026	Form 3: Novo Holdings A/S, 10% owner · Avalyn Pharma Inc
27 Apr 2026	SCHEDULE 13D/A
17 Feb 2026	SCHEDULE 13G/A
17 Feb 2026	SCHEDULE 13G/A
17 Feb 2026	13F-HR
23 Jan 2026	SCHEDULE 13D/A
14 Nov 2025	SCHEDULE 13G/A
14 Nov 2025	SCHEDULE 13G/A

Comments